EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Statins as anti‐tumor agents: A paradigm for repurposed drugs

Sneha Tripathi, Ekta Gupta, Sanjeev Galande iD

Cancer Reports · 2024-05 · 7 (5)

DOI: 10.1002/cnr2.2078 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Reports, online erschienen am 06.05.2024. Verfasst von Sneha Tripathi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Chromatin Biology & Epigenetics, Indian Institute of Science Education and Research, Pune, India. Hauptthemen laut MEDLINE: Hydroxymethylglutaryl-CoA Reductase Inhibitors, Drug Repositioning, Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 277 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Engineering Research Board, Department of Biotechnology, Ministry of Science and Technology, India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Statins, frequently prescribed medications, work by inhibiting the rate‐limiting enzyme HMG‐CoA reductase (HMGCR) in the mevalonate pathway to reduce cholesterol levels. Due to their multifaceted benefits, statins are being adapted for use as cost‐efficient, safe and effective anti‐cancer treatments. Several studies have shown that specific types of cancer are responsive to statin medications since they rely on the mevalonate pathway for their growth and survival. Recent Findings Statin are a class of drugs known for their potent inhibition of cholesterol production and are typically prescribed to treat high cholesterol levels. Nevertheless, there is growing interest in repurposing statins for the treatment of malignant neoplastic diseases, often in conjunction with chemotherapy and radiotherapy. The mechanism behind statin treatment includes targeting apoptosis through the BCL2 signaling pathway, regulating the cell cycle via the p53‐YAP axis, and imparting epigenetic modulations by altering methylation patterns on CpG islands and histone acetylation by downregulating DNMTs and HDACs respectively. Notably, some studies have suggested a potential chemo‐preventive effect, as decreased occurrence of tumor relapse and enhanced survival rate were reported in patients undergoing long‐term statin therapy. However, the definitive endorsement of statin usage in cancer therapy hinges on population based clinical studies with larger patient cohorts and extended follow‐up periods.

Conclusions

The potential of anti‐cancer properties of statins seems to reach beyond their influence on cholesterol production. Further investigations are necessary to uncover their effects on cancer promoting signaling pathways. Given their distinct attributes, statins might emerge as promising contenders in the fight against tumorigenesis, as they appear to enhance the efficacy and address the limitations of conventional cancer treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hydroxymethylglutaryl-CoA Reductase InhibitorsDrug RepositioningNeoplasmsAntineoplastic AgentsHumansSignal TransductionAnimals

Stichwörter der Autor:innen

anti‐cancer drugcholesterolcombinatorial therapydrug repurposinglipid metabolismmevalonate pathwaystatins

Substanzen

Hydroxymethylglutaryl-CoA Reductase InhibitorsAntineoplastic Agents

Autor:innen und Institutionen

  • Laboratory of Chromatin Biology & Epigenetics, Indian Institute of Science Education and Research, Pune, India.
  • Centre of Excellence in Epigenetics, Department of Life Sciences, Shiv Nadar Institution of Eminence, Gautam Buddha Nagar, India.

ORCID-Profile: Sanjeev Galande

Förderung

  • Science and Engineering Research Board
  • Department of Biotechnology, Ministry of Science and Technology, India

Zitieren

APA

Tripathi, S., Gupta, E., & Galande, S. (2024). Statins as anti‐tumor agents: A paradigm for repurposed drugs. Cancer Reports, 7(5). https://doi.org/10.1002/cnr2.2078

Vancouver

Tripathi S, Gupta E, Galande S. Statins as anti‐tumor agents: A paradigm for repurposed drugs. Cancer Reports. 2024;7(5). doi:10.1002/cnr2.2078

BibTeX
@article{Tripathi2024,
  author = {Tripathi, Sneha and Gupta, Ekta and Galande, Sanjeev},
  title = {Statins as anti‐tumor agents: A paradigm for repurposed drugs},
  journal = {Cancer Reports},
  year = {2024},
  volume = {7},
  number = {5},
  doi = {10.1002/cnr2.2078}
}
Kostenlos starten →